Academic conferences present researchers with a fantastic opportunity to share their work, gain feedback, and spark new collaborations. But to attend most conferences you must submit an abstract of completed work, months in advance. What if you’re just getting started? Roni Tibon, together with Rik Henson and other members of the MRC CBU Open Science Committee, raised the issue in a recent article published in Trends in Cognitive Sciences. Here Roni guides us through the problem, and what they see as the solution.
A call for abstract submissions opens for a great conference in July. The deadline is early January. Many of your colleagues are going and it’ll be a wonderful opportunity to get input on your work and learn about other peoples’ research.
But as you check the submission guidelines, you realise that the conference organisers ask for abstracts to include results and conclusions, and you can’t provide any conclusions. Maybe you’re still collecting data, considering your design or haven’t started running your experiment yet. Read more
Eilean MacDonald was diagnosed with childhood arthritis when she was only a baby. 18 years on, as well as dealing with normal teenage life and managing her condition, she’s helping MRC researchers on a stratified medicine study to pick the right treatment, first time, for future patients.
It all started when I was 18 months old and I bumped my knee. My parents noticed that the swelling wouldn’t go down, and took me to our local hospital. They ran tests but the doctors couldn’t figure out what was wrong, so I was referred to the rheumatology department at Alder Hey children’s hospital, where I was diagnosed with Juvenile Idiopathic Arthritis (JIA). Read more
After nearly eight years at the helm of the MRC as Chief Executive, Professor Sir John Savill steps down at the end of March, just before UK Research and Innovation comes into being on 1 April. Here he reflects on how he’s translated his priorities into research investments which will strengthen the UK research ecosystem for the future.
At the end of this week I will have completed an eventful seven and a half years as CEO of the MRC. Thanks to wonderful support from across the MRC’s extended family, much has been achieved for medical research.